As the incidence of NAFLD is rapidly growing, accompanied by overweight and obesity, the need for understanding the pathophysiology is urgent. Based on the concept of our 1st EFLC, the 2nd EFLC 2018 will offer bidirectional crosstalk between basic and clinical research on NASH and its systemic complications. Our mission is to bring together researchers in the field of obesity, diabetes, cardiometabolics and cancer, and to stimulate their involvement in brainstorms and discussions in both plenary and workshop sessions, to come up with solutions, and to create new ideas regarding future directions for international grants, making this congress unique, lively and attractive to join.
Information and registration.
Deadline for Early Bird: 1 December 2017.